Sangon Biotech: difference between revisions
Diff·revision 20 → 21·18:01, 15 Mar 2025
Difference between revision 20 and revision 21 of Sangon Biotech. 8 lines changed; the page grew by 437 bytes.
| Revision 20 — 17:06, 9 Mar 2025 FreightFenna (talk) lead should summarise the body, not add to it 5,478 bytes +201 | Revision 21 — 18:01, 15 Mar 2025 ArchiveBot (talk) bot: expand DOI to full citation 5,915 bytes +437 | ||
|---|---|---|---|
| 33 | No certification claim has been independently corroborated here.{{r|selfpub,gmp}} | 33 | No certification claim has been independently corroborated here.{{r|selfpub,gmp}} |
| 34 | 34 | ||
| + | 35 | == Product range == | |
| + | 36 | | Class | Representative listings | Documentation reported | | |
| + | 37 | |---|---|---| | |
| + | 38 | | Research peptides | Incretin analogues, repair peptides | Certificate, purity; water sometimes | | |
| + | 39 | | Laboratory reagents | Buffers, enzymes, molecular-biology kits | Specification sheet, lot certificate | | |
| + | 40 | | Oligonucleotides | Synthesis to order | Certificate, sequence confirmation | | |
| + | 41 | | SARMs and raw materials | Bulk | Certificate, purity | | |
| + | 42 | ||
| 35 | == References == | 43 | == References == |
| 36 | {{reflist}} | 44 | {{reflist}} |